"Centre d’accueil, d’hébergement, de soins, d’enseignement et de recherche sur la maladie d’Alzheimer."

During the past decade, Institut Claude Pompidou conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Claude Pompidou" #1 collaborator was "Fondation Mederic Alzheimer" with 1 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institut Claude Pompidou" are "Alzheimer's Disease" (2 trials), "Apathy" (2 trials), "Alzheimer Disease" (1 trials), "Cognitive Deterioration" (1 trials) and "Elderly People" (1 trials). Many other conditions were trialed in "Institut Claude Pompidou" in a lesser frequency.

Most popular intervention types in "Institut Claude Pompidou" are "Other" (6 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "A neuropsychological evaluation" (1 trials), "An eye tracking experiment" (1 trials), "Assessment with actigraph" (1 trials), "Assessment with inclinometer" (1 trials) and "Condition classic cognitive stimulation (CCS) then Condition virtual reality (VR)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Claude Pompidou" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Institut Claude Pompidou". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Institut Claude Pompidou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Claude Pompidou, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".